Javascript must be enabled to continue!
Clinical and Hemodynamic Results of Intraaortic Balloon Pumping and Surgery for Cardiogenic Shock
View through CrossRef
The AVCO balloon pump has been employed in treating 40 patients with cardiogenic shock from acute myocardial infarction (CS-MI). All patients were given a trial of medical therapy with hemodynamic monitoring. The time from the development of shock to institution of intraaortic balloon pumping (IABP) was less than 24 hours in all but nine patients. Prior to IABP the mean hemodynamic values were: cardiac index (CI) 1.7 liters/min/m
2
; mean arterial pressure (MAP) 66 mm Hg; pulmonary artery wedge pressure (PAW) 22 mm Hg. After 24-48 hours of IABP the CI and MAP had increased 0.8 liters/min/m
2
and 8 mm Hg, respectively, and the PAW had decreased 4.8 mm Hg. During IABP the shock syndrome was reversed in 31 patients. Four of 25 patients treated with IABP alone survived to be discharged, but two have died from subsequent infarctions. Because of the persistent high mortality, 15 patients judged unable to survive off IABP have undergone emergency surgical procedures with IABP continuing during preoperative angiography and postoperatively. Six were long-term survivors. It is concluded: (1) IABP is a safe, effective means of supporting the circulation in CS-MI; (2) IABP alone will improve survival in some patients; (3) IABP can provide circulatory support during angiography and the perioperative period in patients requiring revascularization for survival; and (4) some patients with CS-MI have myocardial necrosis too extensive to permit survival without permanent circulatory assistance or total cardiac replacement.
Ovid Technologies (Wolters Kluwer Health)
Title: Clinical and Hemodynamic Results of Intraaortic Balloon Pumping and Surgery for Cardiogenic Shock
Description:
The AVCO balloon pump has been employed in treating 40 patients with cardiogenic shock from acute myocardial infarction (CS-MI).
All patients were given a trial of medical therapy with hemodynamic monitoring.
The time from the development of shock to institution of intraaortic balloon pumping (IABP) was less than 24 hours in all but nine patients.
Prior to IABP the mean hemodynamic values were: cardiac index (CI) 1.
7 liters/min/m
2
; mean arterial pressure (MAP) 66 mm Hg; pulmonary artery wedge pressure (PAW) 22 mm Hg.
After 24-48 hours of IABP the CI and MAP had increased 0.
8 liters/min/m
2
and 8 mm Hg, respectively, and the PAW had decreased 4.
8 mm Hg.
During IABP the shock syndrome was reversed in 31 patients.
Four of 25 patients treated with IABP alone survived to be discharged, but two have died from subsequent infarctions.
Because of the persistent high mortality, 15 patients judged unable to survive off IABP have undergone emergency surgical procedures with IABP continuing during preoperative angiography and postoperatively.
Six were long-term survivors.
It is concluded: (1) IABP is a safe, effective means of supporting the circulation in CS-MI; (2) IABP alone will improve survival in some patients; (3) IABP can provide circulatory support during angiography and the perioperative period in patients requiring revascularization for survival; and (4) some patients with CS-MI have myocardial necrosis too extensive to permit survival without permanent circulatory assistance or total cardiac replacement.
Related Results
Percutaneous Coronary Intervention for Acute MI Does not Prevent In-Hospital Development of Cardiogenic Shock Compared to Fibrinolysis
Percutaneous Coronary Intervention for Acute MI Does not Prevent In-Hospital Development of Cardiogenic Shock Compared to Fibrinolysis
Abstract
Background
It has been speculated that invasive revascularization prevents development of cardiogenic shock. Dat...
Preoperative intraaortic balloon pump before urgent coronary bypass grafting
Preoperative intraaortic balloon pump before urgent coronary bypass grafting
Background Urgent or emergency coronary artery bypass grafting in patients with acute coronary syndrome is associated with increased morbidity and mortality. We investigated the ef...
What is the evidence for IABP in STEMI with and without cardiogenic shock?
What is the evidence for IABP in STEMI with and without cardiogenic shock?
Intraaortic balloon pump (IABP) is the most widely used left ventricular support device in a variety of indications. This review focuses on the current literature and discusses the...
Cardiogenic shock classification evaluation after cardiac surgery to predict in-hospital mortality
Cardiogenic shock classification evaluation after cardiac surgery to predict in-hospital mortality
Abstract
Background
The Society for Cardiovascular Angiography and Interventions (SCAI) classification is a risk stratifi...
Long-term dynamics of pesticide metabolites in soil and aquifers
Long-term dynamics of pesticide metabolites in soil and aquifers
Groundwater is one of the most important resources for drinking water, and has to be protected from the input of persistent substances. Nevertheless, pesticides and especially thei...
<b>FREQUENCY OF CARCINOGENIC SHOCK IN PATIENTS WITH NSTEMI</b>
<b>FREQUENCY OF CARCINOGENIC SHOCK IN PATIENTS WITH NSTEMI</b>
Background: Among the various types of acute coronary syndrome, NSTEMI has the most aggravating clinical courses. More severely, the clinical course may present as cardiogenic shoc...
Cardiogenic shock: role of invasive cardiology
Cardiogenic shock: role of invasive cardiology
Purpose of review
Early revascularization significantly improved the outcome of patients with cardiogenic shock following acute myocardial infarction (AMI). Nevertheles...
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Abstract
Introduction
Coronary subclavian steal syndrome (CSSS) is a rare phenomenon that often goes undiagnosed and causes severe complications, including death. This report prese...

